Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “REVIVA PHARMACEUTICALS, INC.”

28 pharma patents match "REVIVA PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 28
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 28 pharmaceutical patents matching "REVIVA PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

28 results for “REVIVA PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 8247420

    Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents

    REVIVA PHARMACEUTICALS, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

  2. US 8207163

    Compositions, synthesis, and methods of using piperazine based antipsychotic agents

    REVIVA PHARMACEUTICALS, INC. · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted

  3. US 8188076

    Compositions, synthesis, and methods of utilizing arylpiperazine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted May 29, 2012 · Expires May 24, 2032

    granted

  4. US 7989500

    Synthesis, methods of using, and compositions of cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.